Emergent BioSolutions shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Emergent BioSolutions
Tip: Access up to 7 years of quarterly data
All positions including Emergent BioSolutions held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Emergent BioSolutions by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $5.8M | 843k | 6.82 |
| 2024-03-31 | $1.8M | 706k | 2.53 |
| 2023-12-31 | $505k | 211k | 2.40 |
| 2023-09-30 | $712k | 210k | 3.40 |
| 2023-03-31 | $475k | 46k | 10.36 |
| 2020-09-30 | $4.1M | 39k | 103.33 |
| 2020-06-30 | $1.8M | 22k | 79.08 |
| 2015-12-31 | $2.0M | 50k | 40.02 |
| 2015-09-30 | $1.2M | 41k | 28.49 |
| 2015-06-30 | $201k | 6.1k | 32.95 |
| 2014-03-31 | $1.5M | 54k | 27.88 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management